Estimating worldwide costs of premature mortalities caused by COVID-19

Silva, J. A. Teixeira da; Tsigaris, Panagiotis

doi:10.1108/jhr-09-2020-0406

Cited by 3 publications

(1 citation statement)

References 17 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“… in time was evaluated by multiplying the total number of close contacts during the infectious period for every new confirmed case in age group ( ) and accounting for the average income of age group during the isolation period ( ), the rate of labor losses during the isolation period ( ), and the estimated number of confirmed cases ( ). Third, the value of a statistical life (VSL) indicates the statistical death cost as dollar units per statistical death during life expectancy 37 . The cost of death for age group in time was calculated by multiplying VSL with the remaining life expectancy for those who died of COVID-19.…”

Section: Methodsmentioning

confidence: 99%

Cost-effectiveness analysis of COVID-19 variants effects in an age-structured model

Cho,

Kim,

Seo

et al. 2023

Sci Rep

View full text Add to dashboard Cite

This study analyzes the impact of COVID-19 variants on cost-effectiveness across age groups, considering vaccination efforts and nonpharmaceutical interventions in Republic of Korea. We aim to assess the costs needed to reduce COVID-19 cases and deaths using age-structured model. The proposed age-structured model analyzes COVID-19 transmission dynamics, evaluates vaccination effectiveness, and assesses the impact of the Delta and Omicron variants. The model is fitted using data from the Republic of Korea between February 2021 and November 2022. The cost-effectiveness of interventions, medical costs, and the cost of death for different age groups are evaluated through analysis. The impact of different variants on cases and deaths is also analyzed, with the Omicron variant increasing transmission rates and decreasing case-fatality rates compared to the Delta variant. The cost of interventions and deaths is higher for older age groups during both outbreaks, with the Omicron outbreak resulting in a higher overall cost due to increased medical costs and interventions. This analysis shows that the daily cost per person for both the Delta and Omicron variants falls within a similar range of approximately $10–$35. This highlights the importance of conducting cost-effect analyses when evaluating the impact of COVID-19 variants.

show abstract

Section: Methodsmentioning

confidence: 99%

Cost-effectiveness analysis of COVID-19 variants effects in an age-structured model

Cho,

Kim,

Seo

et al. 2023

Sci Rep

View full text Add to dashboard Cite

show abstract

Detection of multiple waves for COVID-19 and its optimal control through media awareness and vaccination: study based on some Indian states

Sardar¹,

Nadim

Rana

2022

Nonlinear Dyn

View full text Add to dashboard Cite

COVID-19 is a highly infectious disease, and in very recent times, it has shown a massive impact throughout the globe. Several countries faced the COVID-19 infection waves multiple times. These later waves are more aggressive than the first wave and drastically impact social and economic factors. We developed a mechanistic model with imperfect lockdown effect, reinfection, transmission variability between symptomatic & asymptomatic, and media awareness to focus on the early detection of multiple waves and their control measures. Using daily COVID-19 cases data from six states of India, we estimated several important model parameters. Moreover, we estimated the home quarantine, community, and basic reproduction numbers. We developed an algorithm to carry out global sensitivity analysis (Sobol) of the parameters that influence the number of COVID-19 waves ( ) and the average number of COVID-19 cases in a wave ( ). We have identified some critical controlling parameters that mainly influenced and . Our study also revealed the best COVID-19 control strategy/strategies among vaccination, media awareness, and their combination using an optimal cost-effective study. The detailed analysis suggests that the severity of asymptomatic transmission is around 10% to 29% of that of symptomatic transmission in all six locations. About 1% to 4% of the total population under lockdown may contribute to new COVID-19 infection in all six locations. Optimal cost-effective analysis based on interventions, namely only vaccination (VA), only media awareness (ME), and a combination of vaccination & media (VA+ME), are projected for the period March 14, 2020, to August 31, 2021, for all the six locations. We have found that a large percentage of the population (26% to 45%) must be vaccinated from February 13 to August 31, 2021, to avert an optimal number of COVID-19 cases in these six locations. Supplementary Information The online version contains supplementary material available at 10.1007/s11071-022-07887-5.

show abstract

The economic value of reducing mortality due to noncommunicable diseases and injuries

Verguet,

Bolongaita,

Chang

et al. 2024

Nat Med

View full text Add to dashboard Cite

With population aging, national health systems face difficult trade-offs in allocating resources. The World Bank launched the Healthy Longevity Initiative to generate evidence for investing in policies that can improve healthy longevity and human capital. As part of this initiative, we quantified the economic value of reducing avoidable mortality from major noncommunicable diseases and injuries. We estimated avoidable mortality—the difference between lowest-achieved mortality frontiers and projected mortality trajectories—for each cause of death, for 2000, 2019 and 2050, and for geographic regions, with high-income countries, India and China considered separately; we applied economic values to these estimates. The economic value of reducing cardiovascular disease avoidable mortality would be large for both sexes in all regions, reaching 2–8% of annual income in 2019. For cancers, it would be 5–6% of annual income in high-income countries and China, and for injuries, it would be around 5% in sub-Saharan Africa and Latin America and the Caribbean. Despite the large uncertainty surrounding our estimates, we offer economic values for reducing avoidable mortality by cause and metrics comparable to annual incomes, which enable multisectoral priority setting and are relevant for high-level policy discussions around budget and resource allocations.

show abstract

Estimating worldwide costs of premature mortalities caused by COVID-19

Cited by 3 publications

References 17 publications

Cost-effectiveness analysis of COVID-19 variants effects in an age-structured model

Cost-effectiveness analysis of COVID-19 variants effects in an age-structured model

Detection of multiple waves for COVID-19 and its optimal control through media awareness and vaccination: study based on some Indian states

The economic value of reducing mortality due to noncommunicable diseases and injuries

Contact Info

Product

Resources

About